BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25078895)

  • 1. Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B).
    Power JD; Kavanagh P; O'Brien J; Barry M; Twamley B; Talbot B; Dowling G; Brandt SD
    Drug Test Anal; 2015 Jun; 7(6):512-8. PubMed ID: 25078895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
    Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
    Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of pyrolysis products of the new psychoactive substance 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone hydrochloride (bk-2C-B) and its iodo analogue bk-2C-I.
    Texter KB; Waymach R; Kavanagh PV; O'Brien JE; Talbot B; Brandt SD; Gardner EA
    Drug Test Anal; 2018 Jan; 10(1):229-236. PubMed ID: 28371351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry.
    Theobald DS; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):374-7. PubMed ID: 16978931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
    Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
    J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration.
    Carmo H; de Boer D; Remião F; Carvalho F; dos Reys LA; de Lourdes Bastos M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):143-52. PubMed ID: 15522713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
    Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
    J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium.
    Bertol E; Vaiano F; Mari F; Di Milia MG; Bua S; Supuran CT; Carta F
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):841-849. PubMed ID: 28629236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity involving the hallucinogenic designer amines MDA and 2C-I.
    Drees JC; Stone JA; Wu AH
    J Forensic Sci; 2009 Nov; 54(6):1485-7. PubMed ID: 19878416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
    Vorce SP; Sklerov JH
    J Anal Toxicol; 2004 Sep; 28(6):407-10. PubMed ID: 15516287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 4-bromo-2,5-dimethoxyphenethylamine abuser's urine: identification and quantitation of urinary metabolites.
    Kanamori T; Nagasawa K; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    J Forensic Sci; 2013 Jan; 58(1):279-87. PubMed ID: 23066942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of New Psychoactive Substances in Whole Blood Using Microwave Fast Derivatization and Gas Chromatography/Mass Spectrometry.
    Cláudia M; Pedro A; Tiago R; Francisco CR; Eugenia G
    J Anal Toxicol; 2020 Jan; 44(1):92-102. PubMed ID: 31436798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Analysis of Glucuronic Acid-Conjugated Metabolites of 4-Bromo-2,5-Dimethoxyphenethylamine.
    Kanamori T; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    J Forensic Sci; 2017 Mar; 62(2):488-492. PubMed ID: 27874182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a new drug of abuse: cathinone derivative 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one.
    Weiß JA; Taschwer M; Kunert O; Schmid MG
    J Sep Sci; 2015 Mar; 38(5):825-8. PubMed ID: 25545103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Theobald DS; Staack RF; Puetz M; Maurer HH
    J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques.
    Theobald DS; Pütz M; Schneider E; Maurer HH
    J Mass Spectrom; 2006 Jul; 41(7):872-86. PubMed ID: 16810648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
    Habrdova V; Peters FT; Theobald DS; Maurer HH
    J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of an imidazolium by-product formed during the synthesis of 4-methylmethcathinone (mephedrone).
    Power JD; Kavanagh P; McLaughlin G; O'Brien J; Talbot B; Barry M; Twamley B; Dowling G; Brandt SD
    Drug Test Anal; 2015 Oct; 7(10):894-902. PubMed ID: 25847393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.